Brief: ARAZLO Now Available To Patients Through Provincial Public Drug Plans
Dec 22 (Reuters) - Bausch Health Companies Inc BHC.TO :
* BAUSCH HEALTH COMPANIES - ARAZLO (TAZAROTENE LOTION,
0.045%),
NOW AVAILABLE TO PATIENTS THROUGH QUEBEC, ONTARIO, ALBERTA,
SASKATCHEWAN AND FEDERAL NIHB PUBLIC DRUG PLANS
Source text for Eikon: ID:nCNWxWYj0a
Further company coverage: BHC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bausch Health Companies
See all newsCanada Stocks: TSX heads for monthly gain as mining stocks rise, oil retreats
Canada's Bausch Health Q1 revenue rises
Canada's Bausch Health beats Q1 adjusted EPS estimates
Pfizer, Teva lose bid to disqualify ex-prosecutor in generic drug price‑fixing case
Canada Stocks: TSX subdued as healthcare, financials drag; energy gains